These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8781317

  • 1. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.
    Gregorio GV, Jones H, Choudhuri K, Vegnente A, Bortolotti F, Mieli-Vergani G, Vergani D.
    Hepatology; 1996 Sep; 24(3):520-3. PubMed ID: 8781317
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection.
    Gregorio GV, Pensati P, Iorio R, Vegnente A, Mieli-Vergani G, Vergani D.
    Clin Exp Immunol; 1998 Jun; 112(3):471-6. PubMed ID: 9649217
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies in children with chronic hepatitis B undergoing interferon therapy.
    Kacprzak-Bergman I, Zaleska I, Gruszka J, Kuchar E.
    Med Sci Monit; 2002 Dec; 8(12):CR821-4. PubMed ID: 12503042
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.
    Gatselis NK, Georgiadou SP, Koukoulis GK, Tassopoulos N, Zachou K, Liaskos C, Hatzakis A, Dalekos GN.
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1563-73. PubMed ID: 17094775
    [Abstract] [Full Text] [Related]

  • 9. Autoantibodies during alpha-interferon therapy for chronic hepatitis B.
    Fattovich G, Betterle C, Brollo L, Pedini B, Giustina G, Realdi G, Alberti A, Ruol A.
    J Med Virol; 1991 Jun; 34(2):132-5. PubMed ID: 1890413
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH, Xu XY, Tian GS, Yu YY.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):390-3. PubMed ID: 16677548
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F, Arikan C, Sertoz RY, Nart D, Aydogdu S, Yagci RV.
    Antivir Ther; 2004 Oct 14; 9(5):729-32. PubMed ID: 15535410
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 Oct 14; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Prevalence and significance of non-specific anti-organelle antibodies of the liver in chronic viral hepatitis C].
    Borotto E, Lunel F, Valla D, Abuaf N, Perrin M, Bousquet JC, Opolon P, Homberg JC.
    Gastroenterol Clin Biol; 1994 Oct 14; 18(10):813-8. PubMed ID: 7875387
    [Abstract] [Full Text] [Related]

  • 18. Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.
    Dalekos GN, Galanakis E, Zervou E, Tzoufi M, Lapatsanis PD, Tsianos EV.
    Hepatogastroenterology; 2000 Oct 14; 47(34):1072-6. PubMed ID: 11020882
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.